FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
ALPS Medical Breakthroughs ETF ETF AnalysisComprehensive ETF analysis for ALPS Medical Breakthroughs ETF (SBIO) including NAV, expense ratio, sector breakdown, and holdings data.ETF AnalysisSBIO
SBIO
ALPS Medical Breakthroughs ETF
SBIO
  1. Home
  2. Screener
  3. ALPS Medical Breakthroughs ETFSBIOETF
ALPS Medical Breakthroughs ETF Logo

ALPS Medical Breakthroughs ETF

ETF
🇺🇸SBIO•AMEX•Equity

Your view on SBIO

ALPS Medical Breakthroughs ETF Logo

ALPS Medical Breakthroughs ETF

ETFALPS Funds
🇺🇸SBIO•AMEX•Equity
AUM (USD)$232.86M
Expense Ratio0.5%
Holdings103

Sentiment

AUM (USD)

$232.86M

Expense Ratio

0.5%

Holdings

103

Sentiment

SBIO
ALPS Medical Breakthroughs ETF
SBIO

Overview for ALPS Medical Breakthroughs ETF

Fund Type
ETF
Fund Issuer
ALPS Funds
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
December 30, 2014
Domicile
US
Website
alpsfunds.com/exchange-traded-funds/SBIO
Fund Type
ETF
Fund Issuer
ALPS Funds
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
December 30, 2014
Domicile
US
Website
alpsfunds.com/exchange-traded-funds/SBIO
Fund Type
ETF
Fund Issuer
ALPS Funds
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
December 30, 2014
Domicile
US
Website
alpsfunds.com/exchange-traded-funds/SBIO

About this fund

The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).

SBIO Stock Price

Key Facts

Equity

Expense Ratio

0.5%

AUM

$232.86M

Fund Details

NAV$63.36 USD
Holdings103
Average Volume36.5K
Inception DateDecember 30, 2014
Asset ClassEquity
Fund IssuerALPS Funds
DomicileUS
ISINUS00162Q5936
CUSIP00162Q593
NAV CurrencyUSD

Expense Ratio

0.5%

Assets Under Management

$232.86M

NAV

$63.36 USD

Holdings

103

Average Volume

36.5K

Inception Date

December 30, 2014

Asset Class

Equity

Fund Issuer

ALPS Funds

Domicile

US

ISIN

US00162Q5936

CUSIP

00162Q593

NAV Currency

USD

Expense Ratio

0.5%

Assets Under Management

$232.86M

NAV

$63.36 USD

Holdings

103

Average Volume

36.5K

Inception Date

December 30, 2014

Asset Class

Equity

Fund Issuer

ALPS Funds

Domicile

US

ISIN

US00162Q5936

CUSIP

00162Q593

NAV Currency

USD

Data last updated: Sep 13, 2026, 07:10 AM

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

News

Latest Market News

What is SBIO?

ALPS Medical Breakthroughs ETF (SBIO) is a Equity fund from ALPS Funds, listed since 2014, with $232.9M in assets under management, a 0.50% expense ratio, a NAV of $63.36 USD.

What's in SBIO? Top 10 holdings

HoldingWeight
CG oncology Inc. CGON3.95%
Oruka Therapeutics Inc. ORKA3.63%
Travere Therapeutics Inc. TVTX3.53%
VeraDermics Inc. MANE3.22%
Dianthus Therapeutics Inc. DNTH3.20%
Definium Therapeutics Inc. DFTX3.16%
Edgewise Therapeutics Inc. EWTX2.84%
Relay Therapeutics Inc. RLAY2.76%
Ideaya Biosciences Inc. IDYA2.38%
Xenon Pharmaceuticals Inc. XENE2.36%

SBIO sector breakdown

  • Healthcare 100.00%

Comparable funds

  • AFMCFirst Trust Active Factor Mid Cap ETF
  • EVXVanEck Environmental Services ETF
  • FITEState Street SPDR S&P Kensho Future Security ETF
  • IFGLiShares International Developed Real Estate ETF
  • PBJInvesco Food & Beverage ETF
  • QISSimplify Multi-QIS Alternative ETF

More ALPS Funds ETFs

  • CCNRALPS Funds CoreCommodity Natural Resources ETF
  • DTECALPS Disruptive Technologies ETF
  • EDOGALPS Emerging Sector Dividend Dogs ETF
  • ELFYALPS Electrification Infrastructure ETF
  • ENFRAlerian Energy Infrastructure ETF
  • EQLALPS Equal Sector Weight ETF
  • IDOGALPS International Sector Dividend Dogs ETF
  • LGROLevel Four Large Cap Growth Active ETF
  • MNBDALPS Intermediate Municipal Bond ETF
  • OEFAALPS Funds O’Shares International Developed Quality Dividend ETF
  • OGIGALPS Funds O’Shares Global Internet Giants ETF
  • OUSAALPS Funds O’Shares U.S. Quality Dividend ETF